Immutep Ltd Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Apr 30, 2025 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
IMMUTEP files standard 6-K, no major news.
AI Summary
Immutep Limited filed a Form 6-K on April 29, 2025, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the pharmaceutical preparations sector. This filing does not appear to contain specific financial updates or material events beyond its routine reporting requirements.
Why It Matters
This filing indicates Immutep is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, which is standard practice for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine filing and does not contain new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Immutep Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- April 29, 2025 (date) — Filing date
- Sydney, Australia (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC when they make public certain information that they have made or are required to make public pursuant to the laws of their home country.
When was Immutep Limited previously known by another name?
Immutep Limited was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
Where is Immutep Limited's principal executive office located?
Immutep Limited's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is Immutep Limited's Standard Industrial Classification (SIC) code?
Immutep Limited's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing indicate any new financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine report and does not detail specific new financial results or material events.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2025 regarding IMMUTEP Ltd (PRRUF).